Below, we share with you three mid-cap blend mutual funds, viz. BMSFX, VSEQX and DFVEX. Each has earned a Zacks #1 Rank.
Adolore BioTherapeutics to Present CA8* Neuromodulating Gene Therapy at the 2025 NANS Annual Meeting
DELRAY BEACH, FL / ACCESS Newswire / February 4, 2025 / Adolore BioTherapeutics ("Adolore" or the "Company"), is developing intracellularly-delivered neuromodulators that naturally reduce neuronal ...
“Joining forces with FS Vector represents an exciting new chapter for the company, allowing us to ... Stone-Goff does not make any representation or warranty, express or implied, regarding ...
Vector Inc. engages in the public relations ... and marketing services. The company was founded by Keiji Nishie on March 30, 1993 and is headquartered in Tokyo, Japan.
T-cell therapy represents a groundbreaking advancement in the field of immuno-oncology. This innovative treatment involves ...
It is a mantra that the Danish company has followed for more than 80 years. The Lego brick in its current form was introduced in 1958. The privately-held company is owned by Kjeld Kirk Kristiansen ...
As global markets experience a rebound, driven by cooling U.S. inflation and strong bank earnings, major indices like the S&P 500 and Dow Jones Industrial Average have seen significant gains ...
Blueprint Medicines Corp (NASDAQ:BPMC) reported a challenging fourth quarter for 2024, missing analyst expectations for both earnings per share (EPS) and revenue. The company posted an EPS of -0.79, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results